THBS2 and hepatocellular carcinoma: demonstrated that serum thrombospondin 2 expression levels were significantly associated with advanced fibrosis in NAFLD patients, with HCC observed only in patients with high serum thrombospondin-2, suggesting that this may represent another potential biomarker for surveillance [141].